Here is what you need to know on Wednesday, December 2:
The US dollar is marginally bouncing as President-elect Joe Biden wants to keep tariffs on China unchanged at first. The UK's approval of a coronavirus vaccine helps sustain an upbeat mood. ADP's jobs figures, Fed Chair Powell's testimony, fiscal stimulus, and Brexit are all eyed.
Vaccine: The UK is the first Western country to approve a COVID-19 vaccine, giving the green light to the Pfizer/BioNTech jab, which could be administered as early as next week. The news boosts the market mood.
Sino-American relations: President-elect Joe Biden told the New York Times that he will first conduct a full review and consult allies before removing any tariffs on China. These headlines somewhat weighed on the market mood and allowed the dollar to stabilize.
Fiscal stimulus: A bipartisan group of US Senators unveiled a package worth $908 billion. It is unclear if outgoing President Donald Trump and other politicians back the accord.
Monetary stimulus: Jerome Powell, Chairman of the Federal Reserve, refrained from hinting about expanding the bank's bond-buying scheme in its upcoming decision, but only committed to providing support. He continues testifying on Wednesday.
EUR/USD rallied on Tuesday, hitting the highest since May 2018. The mix of political certainty, a divergence in reactions to monetary stimulus, and vaccine hopes triggered the breakout.
The US ISM Manufacturing Purchasing Managers' Index marginally missed expectations with 57.5 points while the employment component dropped below 50, indicating contraction. The ADP jobs report is due out on Wednesday and provides another clue toward Friday's Nonfarm Payrolls.
Brexit talks continue in full force but the EU denies they have "entered a tunnel" – a term that refers to off-the-radar intense talks are en route to an accord. GBP/USD jumped above 1.34 in hopes for a breakthrough and is holding above that level.
AUD/USD is trading closer to 0.74 amid US dollar weakness and upbeat Gross Domestic Product figures from Australia. The economy grew by 3.3% in the third quarter, better than expected.
Gold has recaptured the $1,800 on Tuesday amid stimulus hopes.
Oil prices continue spilling lower as OPEC+ ministers have yet to reach a deal on output cuts. WTI is changing hands at around $44.
The Canadian dollar is lagging behind some of its peers due to the slide in oil prices and disappointing Canadian GDP, which came out at 40.7% annualized growth in the third quarter.
Cryptocurrencies remain highly volatile. Bitcoin is trading below $19,000 after nearing the round $20,000 level on Tuesday.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.